REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Generica Spol. S R.O. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Generica Spol. S R.O. Profile Updated: October 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Generica spol. s r.o is a company specializing in the research and production of dietary supplements, vitamins, and medical devices. Their products are developed with raw materials and are targeted towards promoting a healthy lifestyle. They serve the domestic market, the Czech Republic, and also export their products successfully.

Headquarters
Vrbovska, c.39
Piestany; Trnavsky; Postal Code: 92101

Contact Details: Purchase the Generica Spol. S R.O. report to view the information.

Website: http://www.generica.sk

Basic Information
Total Employees:
Purchase the Generica Spol. S R.O. report to view the information.
Outstanding Shares:
Purchase the Generica Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Generica Spol. S R.O. report to view the information.
Incorporation Date:
April 04, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Generica Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
4.65%▲
Total operating revenue
4.61%▲
Operating profit (EBIT)
6.78%▲
EBITDA
3.74%▲
Net Profit (Loss) for the Period
4.05%▲
Total assets
-5.96%▼
Total equity
6.65%▲
Operating Profit Margin (ROS)
0.36%▲
Net Profit Margin
-0.08%▼
Return on Equity (ROE)
-0.49%▼
Debt to Equity Ratio
-0.09%▼
Quick Ratio
2.28%▲
Cash Ratio
1.3%▲

Similar companies

Johnson & Johnson, S.R.O.
 
Novartis Slovakia S.R.O.
Saneca Pharmaceuticals A. S.
 
Hbm Pharma S.R.O.
Hartmann - Rico Spol. S R.O.
 
Bb Pharma S.R.O.
Atb Pharma, S.R.O.
 
Panacea, S.R.O.
Farmacia Martin A.S.
 
Galvex, Spol. S R.O.
Biomin, A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo